172 related articles for article (PubMed ID: 15968641)
41. Regulation of cell migration by the C2 domain of the tumor suppressor PTEN.
Raftopoulou M; Etienne-Manneville S; Self A; Nicholls S; Hall A
Science; 2004 Feb; 303(5661):1179-81. PubMed ID: 14976311
[TBL] [Abstract][Full Text] [Related]
42. Negative regulation of CXCR4-mediated chemotaxis by the lipid phosphatase activity of tumor suppressor PTEN.
Gao P; Wange RL; Zhang N; Oppenheim JJ; Howard OM
Blood; 2005 Oct; 106(8):2619-26. PubMed ID: 15994292
[TBL] [Abstract][Full Text] [Related]
43. Adenovirus-mediated transfer of the PTEN gene inhibits human colorectal cancer growth in vitro and in vivo.
Saito Y; Swanson X; Mhashilkar AM; Oida Y; Schrock R; Branch CD; Chada S; Zumstein L; Ramesh R
Gene Ther; 2003 Nov; 10(23):1961-9. PubMed ID: 14528320
[TBL] [Abstract][Full Text] [Related]
44. PTEN reverses MDM2-mediated chemotherapy resistance by interacting with p53 in acute lymphoblastic leukemia cells.
Zhou M; Gu L; Findley HW; Jiang R; Woods WG
Cancer Res; 2003 Oct; 63(19):6357-62. PubMed ID: 14559824
[TBL] [Abstract][Full Text] [Related]
45. The inducible expression of the tumor suppressor gene PTEN promotes apoptosis and decreases cell size by inhibiting the PI3K/Akt pathway in Jurkat T cells.
Xu Z; Stokoe D; Kane LP; Weiss A
Cell Growth Differ; 2002 Jul; 13(7):285-96. PubMed ID: 12133897
[TBL] [Abstract][Full Text] [Related]
46. Inhibition of neuronal phenotype by PTEN in PC12 cells.
Musatov S; Roberts J; Brooks AI; Pena J; Betchen S; Pfaff DW; Kaplitt MG
Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3627-31. PubMed ID: 14990793
[TBL] [Abstract][Full Text] [Related]
47. PTEN and phosphatidylinositol 3'-kinase inhibitors up-regulate p53 and block tumor-induced angiogenesis: evidence for an effect on the tumor and endothelial compartment.
Su JD; Mayo LD; Donner DB; Durden DL
Cancer Res; 2003 Jul; 63(13):3585-92. PubMed ID: 12839945
[TBL] [Abstract][Full Text] [Related]
48. The tumour-suppressor function of PTEN requires an N-terminal lipid-binding motif.
Walker SM; Leslie NR; Perera NM; Batty IH; Downes CP
Biochem J; 2004 Apr; 379(Pt 2):301-7. PubMed ID: 14711368
[TBL] [Abstract][Full Text] [Related]
49. PTEN is recruited to specific microdomains of the plasma membrane during lactacystin-induced neuronal apoptosis.
Choy MS; Bay BH; Cheng HC; Cheung NS
Neurosci Lett; 2006 Sep; 405(1-2):120-5. PubMed ID: 16857313
[TBL] [Abstract][Full Text] [Related]
50. Inhibition of the phosphatidylinositol 3-kinase pathway contributes to HT29 and Caco-2 intestinal cell differentiation.
Wang Q; Wang X; Hernandez A; Kim S; Evers BM
Gastroenterology; 2001 May; 120(6):1381-92. PubMed ID: 11313308
[TBL] [Abstract][Full Text] [Related]
51. Regulation of sensitivity to TRAIL by the PTEN tumor suppressor.
Whang YE; Yuan XJ; Liu Y; Majumder S; Lewis TD
Vitam Horm; 2004; 67():409-26. PubMed ID: 15110188
[TBL] [Abstract][Full Text] [Related]
52. Functional evaluation of PTEN missense mutations using in vitro phosphoinositide phosphatase assay.
Han SY; Kato H; Kato S; Suzuki T; Shibata H; Ishii S; Shiiba K; Matsuno S; Kanamaru R; Ishioka C
Cancer Res; 2000 Jun; 60(12):3147-51. PubMed ID: 10866302
[TBL] [Abstract][Full Text] [Related]
53. Analysis of the cellular functions of PTEN using catalytic domain and C-terminal mutations: differential effects of C-terminal deletion on signalling pathways downstream of phosphoinositide 3-kinase.
Leslie NR; Gray A; Pass I; Orchiston EA; Downes CP
Biochem J; 2000 Mar; 346 Pt 3(Pt 3):827-33. PubMed ID: 10698713
[TBL] [Abstract][Full Text] [Related]
54. Regulation of PTEN (phosphatase and tensin homolog deleted on chromosome 10) expression by estradiol and progesterone in human endometrium.
Guzeloglu-Kayisli O; Kayisli UA; Al-Rejjal R; Zheng W; Luleci G; Arici A
J Clin Endocrinol Metab; 2003 Oct; 88(10):5017-26. PubMed ID: 14557489
[TBL] [Abstract][Full Text] [Related]
55. Regulation of the PTEN phosphatase.
Gericke A; Munson M; Ross AH
Gene; 2006 Jun; 374():1-9. PubMed ID: 16675164
[TBL] [Abstract][Full Text] [Related]
56. PI3 kinase blockade by Ad-PTEN inhibits invasion and induces apoptosis in RGP and metastatic melanoma cells.
Stewart AL; Mhashilkar AM; Yang XH; Ekmekcioglu S; Saito Y; Sieger K; Schrock R; Onishi E; Swanson X; Mumm JB; Zumstein L; Watson GJ; Snary D; Roth JA; Grimm EA; Ramesh R; Chada S
Mol Med; 2002 Aug; 8(8):451-61. PubMed ID: 12435856
[TBL] [Abstract][Full Text] [Related]
57. Reversible oxidation and inactivation of the tumor suppressor PTEN in cells stimulated with peptide growth factors.
Kwon J; Lee SR; Yang KS; Ahn Y; Kim YJ; Stadtman ER; Rhee SG
Proc Natl Acad Sci U S A; 2004 Nov; 101(47):16419-24. PubMed ID: 15534200
[TBL] [Abstract][Full Text] [Related]
58. PTEN regulates motility but not directionality during leukocyte chemotaxis.
Lacalle RA; Gómez-Moutón C; Barber DF; Jiménez-Baranda S; Mira E; Martínez-A C; Carrera AC; Mañes S
J Cell Sci; 2004 Dec; 117(Pt 25):6207-15. PubMed ID: 15564381
[TBL] [Abstract][Full Text] [Related]
59. Impairment of Membrane Lipid Homeostasis by Bichalcone Analog TSWU-BR4 Attenuates Function of GRP78 in Regulation of the Oxidative Balance and Invasion of Cancer Cells.
Lee TL; Wang SG; Chan WL; Lee CH; Wu TS; Lin ML; Chen SS
Cells; 2020 Feb; 9(2):. PubMed ID: 32033487
[TBL] [Abstract][Full Text] [Related]
60. Control of ceramide-induced apoptosis by IGF-1: involvement of PI-3 kinase, caspase-3 and catalase.
Kondo T; Kitano T; Iwai K; Watanabe M; Taguchi Y; Yabu T; Umehara H; Domae N; Uchiyama T; Okazaki T
Cell Death Differ; 2002 Jun; 9(6):682-92. PubMed ID: 12032677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
